ClinicalTrials.gov
ClinicalTrials.gov Menu

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00101595
Recruitment Status : Completed
First Posted : January 13, 2005
Last Update Posted : April 14, 2011
Sponsor:
Information provided by:
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2007
  Actual Study Completion Date : December 2007
  Certification/Extension First Submitted : February 4, 2010
Publications: